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Mutations within the FUS gene (Fused in Sarcoma) are known to cause Amyotrophic
Lateral Sclerosis (ALS), a neurodegenerative disease affecting upper and lower
motoneurons. The FUS gene codes for a multifunctional RNA/DNA-binding protein that
is primarily localized in the nucleus and is involved in cellular processes such as splicing,
translation, mRNA transport and DNA damage response. In this study, we analyzed
pathophysiological alterations associated with ALS related FUS mutations (mFUS) in
human induced pluripotent stem cells (hiPSCs) and hiPSC derived motoneurons. To
that end, we compared cells carrying a mild or severe mFUS in physiological- and/or
stress conditions as well as after induced DNA damage. Following hyperosmolar stress
or irradiation, mFUS hiPS cells recruited significantly more cytoplasmatic FUS into
stress granules accompanied by impaired DNA-damage repair. In motoneurons wild-
type FUS was localized in the nucleus but also deposited as small punctae within
neurites. In motoneurons expressing mFUS the protein was additionally detected in the
cytoplasm and a significantly increased number of large, densely packed FUS positive
stress granules were seen along neurites. The amount of FUS mislocalization correlated
positively with both the onset of the human disease (the earlier the onset the higher
the FUS mislocalization) and the maturation status of the motoneurons. Moreover, even
in non-stressed post-mitotic mFUS motoneurons clear signs of DNA-damage could
be detected. In summary, we found that the susceptibility to cell stress was higher in
mFUS hiPSCs and hiPSC derived motoneurons than in controls and the degree of FUS
mislocalization correlated well with the clinical severity of the underlying ALS related
mFUS. The accumulation of DNA damage and the cellular response to DNA damage
stressors was more pronounced in post-mitotic mFUS motoneurons than in dividing
hiPSCs suggesting that mFUS motoneurons accumulate foci of DNA damage, which in
turn might be directly linked to neurodegeneration.
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INTRODUCTION
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative
disorder characterized by the selective demise of upper and lower
motoneurons (MNs). In most patients, the disease is sporadic
and the pathogenesis is unknown. The identification of genetic
causes [i.e., mutations in of super oxide dismutase-1 (SOD-
1)] gave another scope into understanding familial ALS (fALS).
In 2006, the RNA binding protein TAR DNA-binding protein
43 (TDP-43) encoded by the TARDBP gene was identified as
a major component of ubiquitinated aggregates in ALS and
frontotemporal lobar degeneration (FTLD) (Arai et al., 2006;
Neumann et al., 2006). The identification of TDP-43 as an
important protein in ALS-pathogenesis directly triggered the
discovery of further ALS and FTLD related mutations in the
RNA/DNA-binding protein FUS (Kwiatkowski et al., 2009; Vance
et al., 2009; Blair et al., 2010). FUS is predominantly found in
nuclei (Anderson and Kedersha, 2009) but is also able to shuttle
between the nucleus and the cytoplasm (Dormann and Haass,
2011). FUS seems to be an important factor for the nuclear
export of messenger RNA (mRNA) and the dendritic transport
of mRNA for local translation in neurons (Fujii and Takumi,
2005; Fujii et al., 2005). Furthermore, FUS-positive granules co-
localizing with synaptic markers are also present along dendrites
of mouse neurons and also in the human brain, suggesting an
additional role at synaptic sites (Belly et al., 2010; Aoki et al.,
2012; Schoen et al., 2016). In this respect, it has been described
that upon synaptic mGluR5 activation FUS is translocated to
dendritic spines. FUS deficient mice display disturbed spine
maturation and excessive dendritic branching (Fujii and Takumi,
2005; Fujii et al., 2005). Similarly, transgenic mice expressing
the FUS mutation R521C have transcription and splicing defects
in genes that regulate dendrite outgrowth and synaptic function
(Qiu et al., 2014).
In affected patients carrying FUS mutations, FUS is partially
or totally excluded from the nucleus and forms cytoplasmic
inclusions in neurons (and in glial cells) of the brain and spinal
cord (Neumann et al., 2009; Vance et al., 2009; Dormann et al.,
2010). In some cells, intra-nuclear inclusions have been described
(Neumann et al., 2009; Woulfe et al., 2010). Interestingly, FUS-
ALS-linked mutations are mainly clustered at the C-terminal
region of the protein, which contains the nuclear localization
signal (NLS). Therefore, deletions or mutations in the NLS could
explain the increased cytoplasmic distribution of the FUS protein.
Increasing levels of cytoplasmic FUS are associated with a more
Abbreviations: AA, amino acid; AFP, alpha fetoprotein; ALS, amyotrophic
lateral sclerosis; ChAT, choline acetyltransferase; CRISPR, clustered regularly
interspaced short palindromic repeats; DAPI, 4′,6-diamidino-2-phenylindole;
DDR, DNA-damage response; EB, embryoid body; FGF, fibroblast grow factor;
FTLD, frontotemporal lobar degeneration; FUS, fused in sarcoma; HDAC1,
histone deacetylase-1; hiPSC, human induced pluripotent stem cells; HB9,
homeobox gen-9; iPSC, induced pluripotent stem cells; KLF4, Kruppel-like factor
4; MAP-2, microtubule associated protein-2; MEFs, mouse embryonic fibroblasts;
mFUS, mutated FUS; MN, motoneuron; NANOG, nanog homeobox; NF-H,
neurofilament heavy chain; NLS, nuclear localization signal; OCT4, octamer-
binding transcription factor 4; SEM, standard error of the mean; SG, stress granule;
SOD1, super oxide dismutase-1; SOX2, sex determining region Y-box 2; SSEA4,
stage-specific embryonic antigen; TDP-43, TAR DNA-binding protein; TRA-1,
tumor-related antigen; WT FUS, wild type FUS.
aggressive course of the disease, meaning that mutations that
induce a strong nuclear import defect are usually associated
with an early disease onset and fast disease progression (Bosco
et al., 2010; DeJesus-Hernandez et al., 2010; Dormann et al.,
2010).
Up to now, the exact pathomechanism induced by mutated
FUS (mFUS) in ALS still remains unclear, but there is evidence
that under physiological conditions FUS is involved in DNA
damage responses (DDR) as well as RNA processing and
transcription. In this respect, it was shown that FUS is a
component of DDR machinery since wild type (WT)-FUS is
recruited to DNA damage foci in neurons and interacts with
histone deacyclase-1 (HDAC1), a chromatin modifying enzyme
involved in DDR signaling and DNA repair. Mutations in FUS,
however, presented a weaker HDAC1-interaction leading to
an impaired DDR in neurons. In addition, neuropathological
examination revealed increased DNA damage in cortical and
spinal neurons from fALS patients expressing mFUS variants
(Wang et al., 2013). Along these lines, transgenic mice expressing
human variant FUS-R521C, presented enhanced DNA damage
in cortical and spinal motoneurons and exhibited DNA repair
defects in the 5′ non coding exons of the brain derived
neurotrophic factor gene (Qiu et al., 2014). Moreover, several
studies have demonstrated that ALS related FUS mutations
are directly associated with the formation of cytoplasmic
stress granules (SGs) under stress conditions such as heat
shock and hyperosmolarity (Anderson and Kedersha, 2009).
In fact, pathological inclusions found in brains and spinal
cords from fALS-FUS patients are positive for SG markers
(Bentmann et al., 2012). After hyperosmolar stress, endogenous
FUS is redistributed to the cytoplasm and localized to SGs as
demonstrated by Sama et al. (2014b) in HeLA cells. However,
compared to mFUS that sequesters very strongly into SGs, this
process was found to be less efficient (Bosco et al., 2010; Dormann
et al., 2010; Ito et al., 2011; Bentmann et al., 2012).
The cellular and molecular analysis of ALS pathogenesis has
been impeded by the absence of suitable cell model systems, in
which mutated proteins are usually overexpressed. Post mortem
tissues are also difficult to obtain and mouse models have
been useful but they do not reflect the complete pathology
seen in humans. In this study, we took advantage of the
generation of human induced pluripotent stem cells (hiPSCs)
by reprogramming somatic cells (Aasen et al., 2008; Patel and
Yang, 2010) and derived into various lineages, including spinal
MNs (Stockmann et al., 2013). More importantly, patient-
derived iPSCs lines expressing endogenous mFUS were analyzed.
This provides the possibility to identify the pathophysiological
characteristics of different mutations based directly on patient
specific settings.
We addressed whether the above described pathophysiological
phenotypes associated with mFUS, i.e., FUS mislocalization,
SG formation and enhanced DNA damage are present in
hiPSCs derived from three different fALS-FUS patients under
physiological and stress conditions as well as after induced DNA
damage. To this end hiPS cell lines were generated from fALS-
FUS patients harboring three different endogenous mutations (all
heterozygous) in the FUS C-terminus.
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Only a few studies using hiPS cell lines expressing different
mFUS variants are published up to now showing a cytoplasmatic
distribution of FUS in mFUS hiPSC derived spinal MN (Lenzi
et al., 2015; Liu et al., 2015; Ichiyanagi et al., 2016; Naujock
et al., 2016) and an enhanced recruitment of FUS into SGs
after the induction of cellular stress. Similarly, in hiPSC-derived
cortical neurons expressing different mFUS variants (a mild
mutation R521C and an aggressive mutation R495QfsX527),
cytoplasmic FUS inclusions were spontaneously formed and were
dependent on both, the severity of the mutation and neuronal
age. Furthermore, the severity of the FUS mutation determined
the cell vulnerability to oxidative stress (Japtok et al., 2015). In
addition to the two previously described mutations, we generated
and differentiated an additional hiPSC line from a juvenile ALS-
patient with a severe de novo FUS mutation Asp502Thrfs∗27
(Hübers et al., 2015). Undifferentiated cells were not only exposed
to hyperosmolar stress (Lenzi et al., 2015) but also to DNA
damage induction. We found that hyperosmolar stress as well
as DNA damage induced preferentially recruitment of FUS into
SGs in cells expressing mFUS and this correlated well with the
severity of the underlying mutation. More interestingly, iPSCs
were unable to repair the DNA properly. In spinal MNs the
extra-nuclear localization of FUS was directly correlated with
the stage of neuronal aging and the onset of the disease. Young
MNs harboring the most aggressive mutation presented FUS
delocalization and spontaneous DNA-damage accumulation.
Moreover, in control cells FUS was detectable in small punctae
along neurites (Belly et al., 2010; Aoki et al., 2012; Schoen et al.,
2016). In mutant MN, however, an increased number of large,
densely packed FUS positive SG were formed spontaneously
along the neurites.
MATERIALS AND METHODS
Cultivation of Human Keratinocytes and
Mouse Embryonic Fibroblasts
Generation of iPSC lines from hair keratinocytes as well as
the cultivation of CD-1 mouse embryonic fibroblasts (MEFs)
(day E14.5) (Stemcell Technologies, Vancouver; CA, USA) was
performed as previously described (Takahashi and Yamanaka,
2006; Aasen et al., 2008).
Generation of Lentiviruses
Viral particles were produced according to published protocols.
For more detailed information, see Linta et al. (2012) and
Stockmann et al. (2013).
Generation and Cultivation of Human
iPSCs
Human keratinocytes were reprogrammed as previously
described (Stockmann et al., 2013) using a lentiviral polycystronic
STEMCCA cassette encoding octamer-binding transcription
factor 4 (OCT4), sex determining region Y-box 2 (SOX2),
Kruppel-like factor 4 (KLF4), and c-MYC (Somers et al., 2012).
Briefly, keratinocytes (75% confluence) were treated with
5 × 105 proviral genome copies in EpiLife medium (Invitrogen,
Carlsbad, CA, USA) supplemented with 8 µg/ml polybrene
(Sigma-Aldrich, St. Louis, MO, USA) on two subsequent
days. Afterwards, keratinocytes were detached with TrypLE
Express (Invitrogen, Carlsbad, CA, USA) for 10 min at 37◦C
and transferred to previously irradiated (30Gy) rat embryonic
fibroblasts feeder cells. Keratinocytes were cultured in hiPSC
medium consisting of knockout/DMEM supplemented with
20% knockout serum replacement, 2 mM GlutaMAX, 100 mM
non-essential amino acids (all from Life technologies), 1%
Antibiotic–Antimycotic, 100 mM β-mercaptoethanol (Millipore,
USA), 50 mg/ml vitamin C, and 10 ng/ml fibroblast growth factor
(FGF-2) (both from PeproTech, USA) in a 5% O2 incubator.
Medium was changed daily. After 3–5 days small colonies
appeared with typical hiPSCs morphology. Around 14 days
later, hiPSC colonies had the appropriate size for mechanical
passaging and were transferred onto irradiated MEFs (Stem
Cell Technologies, France) and further cultivated with hiPSC
medium. After one passage hiPSC colonies were mechanically
picked and transferred to feeder free plates and maintained
with mTReSR1 medium (Stem Cell Technologies, France). For
splitting, hiPSCs colonies were incubated with dispase (StemCell
Technologies) for 5–7 min at 37◦C and subsequently detached
using a cell scraper. For more detailed methods see Stockmann
et al. (2013).
The reprogramming of the human fibroblasts was performed
essentially as described by Reinhardt et al. (2013) and Lojewski
et al. (2014) using pMX-based retroviral vectors encoding human
Yamanaka factors (Reinhardt et al., 2013; Lojewski et al., 2014).
For infection, up to 50 000 fibroblasts per well of a 0.1% gelatin-
coated 6-well-plate were infected three times with pMX vectors
in combination with 6 µg/ml protamine sulfate (Sigma-Aldrich)
and 5 ng/ml FGF-2 (Peprotech). Infected fibroblasts were plated
onto mitomycin C (MMC, Tocris) inactivated CF-1-MEFs. The
next day media was exchanged to ES medium containing 78%
Knock-out DMEM, 20% Knock-out serum replacement, 1% non-
essential amino acids, 1% penicillin/streptomycin/glutamine and
50 µM β-Mercaptoethanol (all from Invitrogen) supplemented
with 5 ng/ml FGF-2 and 1 mM valproic acid (Sigma Aldrich).
Media was changed every day to the same conditions. Seven days
after viral infection hiPSC-like cells appeared and were cultured
for additional 7 days. At day 14 post-infection, the cells were
manually picked and plated on CF-1 feeder cells in ES medium
supplemented with 5 ng/ml FGF-2. By using 1 mg/ml collagenase
type IV (Invitrogen) constant colonies were passaged on CF-1
feeder cells (Globalstem, Gaithersburg, MD, USA) treated with
MMC. Addition of 10 µM Rock-inhibitor Y-27632 for the first
48 h improved survival of hiPSCs. Medium was changed daily
and contained FGF-2. The cultivation of generated hiPSCs at
later passages was performed essentially as described (Stockmann
et al., 2013) under feeder- and serum-free conditions.
Characterization of Pluripotency and
In vitro Differentiation of EBs
The pluripotency tests and the germ-layer-specific detection was
performed as previously described (Linta et al., 2012; Stockmann
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et al., 2013) or done according to the manufacturer’s protocol
using the StemLite Pluripotency Kit (Cell Signaling, Danvers,
MA, USA). For in vitro differentiation, hiPSC colonies were
mechanically lifted by dispase (Stemcell Technologies) digested
and transferred in T75 low-attachment flasks (Corning, Corning,
NY, USA). Embryoid body (EB) formation was performed in
suspension in knockout DMEM supplemented with 2 mM
GlutaMAX, 20% Knockout Serum Replacement (Invitrogen,
Carlsbad, CA, USA), 1% Antibiotic-Antimycotic (Invitrogen),
100 µM nonessential amino acids (Invitrogen), and 100 µM ß-
mercaptoethanol (Invitrogen) for 10 days. Afterwards, EBs were
plated on 35 mm dishes (Ibidi, Munich, BY, Germany) and kept in
culture for up to 14 days. Differentiated EBs were stained 1:1000
chicken anti-Tubulin beta-III (Millipore, Billerica, MA, USA);
1:150 mouse anti-Actinin (Sigma Aldrich) and 1:100 goat anti-
AFP (Santa Cruz, CA, USA). Alexa fluor secondary antibodies
were used from Invitrogen.
Karyotyping
Karyograms of all generated iPSC lines were analyzed to exclude
chromosomal aberrations after reprograming. Chromosome
preparation of hiPS cells was performed according to standard
procedures (Linta et al., 2012). Briefly, two confluent wells
of a six-well-plate were prepared. 1.5 M Colchicine (20 mg/l,
Eurobio, Courtaboeuf, France) was added for 2 h to conserve
metaphases. Treated cells were detached with TrypLE for 4 min
at 37◦C. Cultures represent normal male/female karyotypes (see
Supplementary Figure S1C).
Differentiation of hiPSCs into Mature
Spinal Motoneurons
Motoneuronal differentiation of hiPSCs was performed as
previously described by Hu and Zhang (2009). Modifications of
the experimental protocol have been adopted from Stockmann
et al. (2013). Motoneurons were fixed for immunochemical
analysis after 21 and 42 days after final plating.
Generation of Isogenic
R495QfsX527c.1483insC
Clustered regularly interspaced short palindromic repeats
(CRISPR) technology was used to generate an isogenic CNTL cell
line derived from R495QfsX527 cell line, by inserting in position
1483 a cytosine (C), which is deleted in the patient cells, and
consequently correcting the mutation.
Two sgRNAs (TATGATCGAGGCGGCTACCGGG, CGAGG
GGGCCGGGGTGGTGGGG, Sigma-Aldrich) and a vector
(Genewiz, UK) carrying the template (c-nucleotide, 731 bp
up- and 715 bp downstream of the insertion site) were
designed and transfected into a single iPS cells via human
stem cell nucleofection kit using an AMAXA nucleofector (both
from Lonza, Cologne, Germany). Cells were screened using
a PCR based approach. After generation of isogenic CNTL
line R495QfsX527c.1483insC, following CRISPR (Supplementary
Figure S2A), the sequences upstream and downstream of the
insertion site were sequenced to exclude additional alterations.
Except for the cytosine insertion (highlighted in red) and the
two proto-spacer adjacent motifs (PAM, highlighted in green),
the alignment of the sequencing results of genomic CNTL and
R495QfsX527c.1483insC revealed no further alterations within the
fragment (Supplementary Figure S2B).
Immunocytochemistry
Immunochemical analysis were performed as previously
described in standard protocols (Takahashi and Yamanaka,
2006; Aasen et al., 2008; Stockmann et al., 2013). HiPSCs
and MNs were fixed by using 4% paraformaldehyde and
10% sucrose in phosphate buffered saline (PBS, Invitrogen).
Primary antibodies were used under described incubation
conditions: 1:1000 rabbit anti-FUS (Bethyl Labs, Montgomery,
TX, USA); 1:2000 goat anti-TIA-1 (Santa Cruz Biotechnology,
Heidelberg, Germany); 1:1000 chicken anti-tubulin beta-III
(Millipore, Darmstadt, HE, Germany); 1:1000 chicken anti-NF-
H (Antibodies online, Aachen, NRW, Germany); 1:1000 mouse
anti-MAP-2 (Millipore, Darmstadt, HE, Germany); 1:1000 rabbit
anti-γH2A.X (phosphor S139) (abcam, Cambridge, UK); 1:1000
chicken anti-ChAT (abcam), 1:1000 rabbit anti-Islet1 (ISL1)
(abcam, Cambridge, UK); 1:300 mouse anti-(homeobox gen)
(HB)-9 (DSHB, Iowa City, IA, USA), 1:200 rabbit anti-(nanog
homeobox) (NANOG), 1:200 rabbit anti-OCT4, 1:200 rabbit
anti-SOX2, 1:200 mouse anti-SSEA4, 1:200 mouse anti-(tumor-
related antigen)-TRA1-60, 1:200 mouse anti-TRA1-81 (all
Invitrogen) for 12 h at 4◦C. Following fluorescence, labeled
secondary antibodies were used: green Alexa Fluor R© 488,
red Alexa Fluor R© 568, magenta Alexa Fluor R© 647 (all 1:500,
Invitrogen). Glass cover slides were mounted with ProLong Gold
Antifade reagent with DAPI (Invitrogen). Images were analyzed
with a fluorescent microscope (Axiokop 2, Zeiss, Oberkochen,
BW, Germany) using a CCD camera (16 bits; 1024 pixels per
image) and the axiovision software (Zeiss).
Western Blot
Western Blots were performed as previously described
(Grabrucker et al., 2011). Protein concentration was determined
by Bradford Assay; equal amounts of protein were separated
using SDS-PAGE (polyacrylamide gel electrophoresis) and
subsequently blotted on nitrocellulose membrane (GE
Healthcare, Germany). Immunodetection of the primary
antibody (Caspase-3, 1:500, Cell signaling, Danvers, MA, USA)
was visualized by HRP-conjugated secondary antibody and
ECL detection kit (Thermo Scientific). For quantification,
Gel-analyzer Software 2010a was used. Subsequently, values were
normalized against the loading control ß-actin (1:250.000, Sigma
Aldrich. St. Louis, MO, USA).
Induction of Cell Stress by Sorbitol and
γ-Irradiation
Control and mFUS iPSCs were seeded on hESC-qualified-
matrigel coated 13 mm glass cover slides (Menzel, Braunschweig,
Germany) 1 day before treatment. To ensure a final concentration
of 0.3 M, Sorbitol (Sigma-Aldrich, Schnelldorf, BW, Germany)
was dissolved directly into pre-warmed mTeSR1 medium
(Stemcell Technologies, Vancouver, CA, USA). Media was
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sterile-filtered and added to the cells followed by immediate
incubation at 37◦C for 30 min. Afterwards treated cells were fixed
for immunostaining. In order to remove dead cells, medium was
changed 1 h before treatment.
To analyze enhanced sensitivity of patient derived iPSCs
to DNA damage, DNA breaks were induced by γ-irradiation
(0.5 Gy) in control and mFUS hiPSC cell lines. Cells were
lifted via hESC-dispase digestion (Stemcell Technologies) and
transferred in suspension to a falcon tube. HiPSCs were then
exposed to radiation and carefully seeded on hESC-qualified-
matrigel coated 13 mm glass cover slides for immunochemical
analysis. Subsequently, hiPSCs were analyzed after 24 h
cultivation in mTeSR1 medium by quantifying cell colonies
presenting normal/healthy or fragmented/apoptotic nuclei. To
remove dead cells medium was changed 1 h before the fixation.
All existing colonies from three cover slides were analyzed
per experiment and condition. Subsequently, to determine
the amount of double strand breaks after irradiation the
samples were immunostained for rabbit anti-γH2A.X (abcam,
1:2000). To analyze, quantification of DNA damage foci
positive cells were counted. Each experiment was repeated three
times.
To analyze sensitivity of motoneurons expressing WT
FUS or mFUS the neuronal spheres were plated on
35 mm dishes and kept in culture for 21/42 days. Medium
was changed two times per week. The DNA breaks
were induced by γ-irradiation (0.5 Gy) in control and
mFUS MNs. Cells were fixed and analyzed after 24 h of
cultivation by the quantification of DNA damage foci positive
cells.
Comet Assay
The comet assay was performed according to a standard protocol
(Speit and Hartmann, 2006). HiSPC were lifted via hESC-dispase
digestion (Stemcell Technologies) and transferred in suspension
to a falcon tube. Afterwards iPSCs were exposed to γ-irradiation
(0.5 Gy) and 10 µl cell suspension (about 10 000 cells) was
mixed with 120 µl low melting point agarose (0.5% in PBS)
and added to microscope slides (with frosted ends), which had
been covered with a bottom layer of 1.5% agarose. Slides were
then lysed (pH 10; 4◦C) for at least 1 h. Slides were processed
using alkali denaturation (at a pH > 13) for 25 min and
followed by electrophoresis (0.86 V/cm). Images of 100 randomly
selected cells stained with ethidium bromide were analyzed from
each slide. Measurements were made by image analysis (Comet
Assay IV, Perceptive Instruments, Haverhill, UK) and DNA
migration was determined by measuring the “tail intensity” (%
tail DNA). All samples were processed “double blinded” and
analyzed by one researcher to reduce variability. Each experiment
was performed independently three times, and the mean was
calculated.
Data Analysis and Statistics
For counting hiPS cells on each coverslip (n = 3) 3–10
representative images were taken randomly. Cells containing
FUS positive inclusions under each condition (±sorbitol or
±irradiation) and the total number of cells labeled with DAPI
were counted by using Image J Software1. Then, the mean of the
positive cells/total number of cells ratio was calculated for each
experiment (n = 3) and presented relative to untreated CNTL.
Each specific type of colony (healthy, apoptotic, differentiated,
and clumpy) ±irradiation was counted and expressed as a
percentage of the total number of colonies relative to untreated
CNTL. Cells positive for γH2A.X foci (either iPSC or MN) were
counted and the number expressed as the percentage of the total
number cells, in the same way as described for the number of cells
containing FUS positive inclusions. According to the parameters,
values were statistically analyzed either by one way ANOVA with
a Bonferroni post hoc test to compare different cell lines or a
unpaired t-test to compare two different conditions as indicated
in each figure.
For quantification of FUS and TIA1 foci along neurites the
“Find Foci plugin” (ImageJ) was used, which has previously
been shown to closely match human assignments and reduce
human inconsistencies in foci detection (Herbert et al., 2014).
FUS, which co-localized with TIA1 foci were selected using a
custom written program. Those foci could then be re-analyzed
separately using “Find Foci.” In order to increase performance,
spatial co-localization analysis was implemented using Python
3.5.1 in the Anaconda distribution. Imaging features of the
scikit-image module (Van Der Walt et al., 2014) were used for
loading and saving of image files. The masks created by the
find foci plugin were processed. Masks of the FUS and TIA
channel were processed pairwise. Every selection area in the first
mask (FUS) was checked for a corresponding area in the second
channel (TIA1). If such an overlap was found, both signals were
deemed as spatially co-localizing. Non-co-localizing selections
were removed and two new output masks were saved: a TIA1
mask and a FUS mask. These new masks only selected signals
when at least a partial overlap with the other channel was found.
They were used as input masks for “find foci” in order to analyze
only these signals. The program was processed into a distributable
file using PyInstaller. Single neurites (15–21) from five different
cultures were analyzed per cell line. For Intensity measurements
a minimum of 66 cells from three different cultures was analyzed.
The signal intensity was quantified using ImageJ. An unpaired
t-test was performed to compare CNTL versus mFUS.
All fluorescence images were obtained with an upright
Axioscope microscope equipped with a Zeiss CCD camera (16
bits; 1280 ppi × 1024 ppi) using Axiovision software (Zeiss).
All statistical analyses were performed using GraphPad Prism 5
(GraphPad Software Inc., La Jolla, CA, USA) software. Results are
represented as mean values± SEM. Statistical significance levels
were set to p= 0.05.
Ethics Statement
All procedures with human material were in accordance with
the ethical committee of the Ulm University (Nr. 0148/2009 or
265/12) and Technische Universität Dresden (EK45022009) and
in compliance with the guidelines of the Federal Government of
Germany (Nr. O.103). The use of human material was approved
by the Declaration of Helsinki concerning Ethical Principles for
1www.imageJ.nih.gov
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Medical Research Involving Human Subjects (Stockmann et al.,
2013). All participants gave informed consent for the study.
RESULTS
Characterization of hiPSC Lines
We generated and differentiated patient-derived cells lines
(FUS1, FUS2, and FUS3) carrying three different endogenous
mutations (all heterozygous) within the FUS gene. FUS1
harbored a “mild” missense mutation (R521C) with a late onset
(57 years old), family history of ALS (Japtok et al., 2015), and
a disease duration of 7 months. Cell line FUS2 carried the
“malign” novel 1 bp deletion c.1483delC leading to a frameshift
and the translation of 33 “new” amino acids before the STOP
codon (R495QfsX527; Belzil et al., 2012; Japtok et al., 2015;
Lenzi et al., 2015). This mutation presented with a juvenile
ALS onset (27 years old) and death 16 months after onset. The
patient-derived cell line FUS3 carried the most severe frameshift
mutation c.1504delG. This leads to a modification of the FUS
protein-coding sequence of exon 14 and 15 within a highly
conserved region (RGG-rich). In addition and due to the loss
of a functional stop codon, the translation of the protein is
extended into the 3′-UTR (Asp502Thrfs∗27). This mutation leads
to an early juvenile onset of ALS (19 at disease onset). All
patients had a spinal onset, to a bulbar disease progression for
FUS1 and FUS2. Patient-derived cell lines were compared with
three control cell lines (CNTL1, CNTL2, and CNTL3) derived
from neurologically healthy volunteers (male, age 29; female,
age 45; male, age 79). Moreover, we corrected the mutation
of the FUS2 line by CRISPR technology (Supplementary
Figure S2) to test for mutation specific phenotypes (isogenic
CNTL cell line R495QfsX527c.1483insC) (Table 1). All established
hiPS cell lines (Asp502Thrfs∗27 is shown as an example)
were checked for the expression of characteristic pluripotency
markers including the nuclear factors OCT4, SOX2, NANOG
and SSEA-4,TRA-1-60 and TRA-1-81 (Supplementary Figures
S1A,B or as previously published (Japtok et al., 2015; Naujock
et al., 2016). To confirm the ability of iPSCs to differentiate
into ectoderm, endoderm, and mesoderm, specific markers
were analyzed by immunocytochemistry including tubulin-ß-
III, actinin, and AFP (Supplementary Figure S1C). Similarly,
the generated iPSC line R495QfsX527c.1483insC was positive for
specific pluripotency markers. R495QfsX527c.1483insC expressed
the nuclear factors (all green) SOX2, OCT4 and NANOG and
the surface markers (all red) SSEA-4, TRA1-60 and TRA1-81.
The generated cell line showed high endogenous mRNA levels
for SOX2, OCT4, and NANOG, whereas KLF4 showed lower
expression levels (Supplementary Figure S2C). In addition, cell
lines presented normal karyotypes as shown in Supplementary
Figure S1D.
HiPSCs Expressing mFUS Are More
Sensitive to Hyperosmolar Stress and
Induced DNA Damage
In hiPSCs of control cell lines expressing WT FUS and hiPSC
expressing mFUS, FUS was localized predominantly in the
nucleus (Supplementary Figure S1E). Low levels of cytoplasmic
FUS were detectable in some cells of the control cell lines
CNTL1 and CNTL2 as well as in the cell lines carrying the
R521C and R495QfsX527 mutations, but to a negligible degree
(see arrowheads). Isogenic CNTL cell line R495QfsX527c.1483insC
confirmed this observation and showed also predominantly
nuclear FUS (Supplementary Figure S2D). However, even at this
early iPSC stage, some cells within the iPSC colonies from the
mFUS cell line Asp502Thrfs∗27 exhibited a stronger cytosolic
FUS mislocalization when compared to the other cell lines
(Supplementary Figure S1E).
TABLE 1 | Human control and mFUS iPSC lines harboring different mutations of the FUS gene.
Cell line Gender Age∗ Mutation Clinical Additional information
FUS1 Female 57 (58) (58) R521C, missense Spinal Onset (arms), rapid progression
to bulbar, disease duration 7 months
died from respiratory failure
Family history of ALS with different
phenotypes
FUS2 Male 26 (28) (28) R495QfsX527 (c.1483delC),
frameshift
Spinal onset (legs), upper and lower
motoneuron involvement, hyperintense
pyramidal tract in brain MRI; loss of
walking ability 5 months after symptom
; non-invasive ventilation 10 months
after symptom onset; death 16 months
after onset
Juvenile ALS; de novo FUS mutation,
both parents were tested negative
FUS3 Male 19 (20) (n.a) Asp502ThrfS∗27 (c.1504delG),
frameshift
Spinal onset (right hand, spreading to
right leg, bulbar involvement during
disease course); predominantly lower
motoneuron involvement
Juvenile ALS, de novo FUS mutation,
both parents were tested negative
CNTL1 Male 29 – –
CNTL2 Female 45 – –
CNTL3 Male 79 – Father of FUS2
ISOGENIC CNTL Male 26 R495QfsX527 c.1483InsC Corrected mutation FUS2
∗Age at onset (age at keratinocytes preparation/biopsy) (age of death).
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FIGURE 1 | Hyperosmolar stress induces cytoplasmic FUS positive SGs in mFUS-hiPSCs. FUS immunostainings showing the nuclear distribution of
wildtype and mFUS protein (green) in hiPSC lines (A) before and (B) after hyperosmolar stress conditions. In control and mFUS-hiPSC lines, FUS+ granules as well
as TIA1+ SGs were detectable after stress. TIA1+ SGs are immunopositive for FUS as indicated by arrowheads. (C) Quantification of the amount of cells containing
FUS+/TIA1+ SGs in mFUS cell lines relative to control. Statistical analysis revealed that after hyperosmolar stress all cell lines show a significant increase in FUS+
aggregates indicated by red asterisks (CNTL− vs. CNTL+ p ≤ 0.001, R521C− vs. R521C+ p ≤ 0.001, R495QfsX527− vs. R495QfsX527+ p ≤ 0.001,
Asp502ThrfS∗27− vs. Asp502ThrfS∗27+ p ≤ 0.001). Unpaired t-test to compare untreated vs. treated; indicated by red asterisk. The increase was significantly
higher in the mFUS cell lines (CNTL+ vs. R521C+, R495QfsX527+, Asp502ThrfS∗27+ p ≤ 0.001). Statistically significant differences were determined by one way
ANOVA with Bonferroni post hoc test to compare individual groups. ∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001, + = sorbitol (0.3 M), CNTL = control, mFUS = mutated
FUS, SGs = stress granuls. Scale bars: 10 µm.
Hyperosmolar stress was induced by exposing the hiPSCs
to 0.3 M sorbitol for 30 min. Unstressed hiPSCs showed
typical stem cell morphology with oval nuclei lying close
to each other. Cells expressing WT or mFUS displayed a
predominantly nuclear FUS localization in the absence of sorbitol
or following mock-treatment (Figure 1A, green arrowheads).
In addition, in unstressed control cells the SG marker TIA1
was found within nuclei (red arrowheads) and in some cells
in the cytoplasm (yellow arrowheads, Figure 1A). In patient-
derived cell lines expressing mFUS R521C, R495QfsX527 and
Asp502ThrfS∗27 the TIA1 signal was also mainly nuclear without
any cytoplasmic localization (Figure 1A). After hyperosmolar
stress, however, FUS was seen in the cytoplasm forming several
granules (green arrowheads, Figure 1B). This was seen in
the control cell line as well as in all mFUS expressing cell
lines. FUS+ granules perfectly co-localized with TIA1 (red
arrowheads) indicating a specific localization of FUS to SGs
(Figure 1B). Quantification of cells containing FUS+ cytoplasmic
inclusions showed that in unstressed hiPSCs lines a very
low proportion of cells displayed FUS aggregation and there
were no significant differences between control and patient-
derived cell lines (Figure 1C). After treatment with sorbitol, all
cell lines responded to the treatment by having a significant
proportion of cells containing FUS+ granules. This increase was
5.65 ± 0.42 fold in the control cell line CNTL and 6.02 ± 0.61,
9.50 ± 0.81, and 11.8 ± 1.12 fold in the mFUS cell lines R521C,
R495QfsX527 and Asp502Thrfs∗27, respectively (p ≤ 0.001,
unpaired t-test to compare non-treated versus treated cells within
each cell line; red asterisk) (Figure 1C). The comparison of
FUS/TIA1 inclusions of mFUS lines with controls after sorbitol
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FIGURE 2 | mFUS-hiPSC are highly sensitive to induced DNA damage by irradiation. (A) Classification of γH2A.X foci in hiPSCs from both controls or mFUS:
(I) no foci (II) low and high level of foci. A representative image of Asp502ThrfS∗27 is shown. (B) The number of cells showing γH2A.X foci were nearly identical in all
groups before irradiation; after irradiation the cell lines R495QfsX527 and R521C showed a significant increase of γH2A.X+ cells. Moreover, the R495QfsX527 line
showed more affected cells than irradiated control and irradiated R521C (unpaired t-test to compare non-irradiated versus irradiated conditions within each cell line
was performed; indicated by red asterisks, R521− vs. R521C+ p ≤ 0.05 and R495QfsX527− vs. R495QfsX527+ p ≤ 0.001). The effect of irradiation between the
cell lines was analyzed by one way ANOVA with Bonferroni post hoc test to compare different groups, CNTL+ vs. R495QfsX527+ p ≤ 0.01 and R521C+ vs.
R495QfsX527+ p ≤ 0.05. (C) Classification of hiPSC colonies in: (I) healthy, (II) apoptotic, (III) differentiated, and (IV) clumpy. (D) Apoptotic colonies were increased
after irradiation (unpaired t-test to compare non-irradiated versus irradiated cells within each cell line was performed; indicated by red asterisks, CNTL vs. CNTL+
p ≤ 0.01, R521C vs. R521C+ p ≤ 0.01, R495QfsX527 vs. R495QfsX527+ p ≤ 0.01, Asp502ThrfS∗27 vs. Asp502ThrfS∗27+ p ≤ 0.001) and apoptosis was highly
elevated in mFUS cells compared to control. The amount of differentiated and clumping colonies showed no differences after irradiation (data not shown). Analysis of
significance was performed by one way ANOVA with Bonferroni post hoc test to compare different groups (CNTL+, R521C+ and R495QfsX527+ vs.
p.Asp502Thrfs∗27+ ∗∗∗p ≤ 0.001). (E) The tail intensity (Comet assay after irradiation) of cell line CNTL and p.Asp502Thrfs∗27 was significantly increased as
indicated by red asterisks but showed no differences between the control and mFUS cell line (one way ANOVA with Bonferroni post hoc test CNTL− vs. CNTL+ and
Asp502ThrfS∗27− vs. Asp502ThrfS∗27+ p ≤ 0.001). ∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001, + = irradiation (0.5 Gy), CNTL = control, mFUS = mutated FUS. Scale
bars: 10 µm.
treatment revealed a highly significant increase (CNTL vs.
R521C, R495QfsX527 and Asp502Thrfs∗27 p ≤ 0.001, one way
ANOVA with Bonferroni post hoc test to compare different
groups).
Next we analyzed the susceptibility of hiPSCs specifically
to DNA damage and repair by the induction of DNA breaks
(γ-irradiation). DNA damage in hiPSC colonies was measured by
immunolabeling γH2A.X positive foci (phosphorylated protein
is recruited to DNA double strand breaks as depicted in
Figures 2AI,II), which are proportional to the amount of DNA
breaks (Fillingham et al., 2006). Cells were analyzed by counting
the percentage of nuclei containing γH2A.X foci before and 24 h
after irradiation. At base line, all cell lines presented a low number
of the cells with γ-H2A.X foci but 24 h after DNA damage
induction a significant increase was detected in the mFUS lines
R521C (1.6 ± 0.07, p ≤ 0.05) and R495QfsX527 (2.464 ± 0.107
p≤ 0.01). No increase was seen in the control cell line (1.4± 0.1)
(Figure 2B) indicating that in the mFUS cell lines a higher
number of DNA breaks was still detectable after 24 h of repair
time (CNTL vs. R495QfsX527, p ≤ 0.01 and vs. R521C, p ≤ 0.05,
one way ANOVA with Bonferroni post hoc test to compare
different groups). The mFUS Asp502Thrfs∗27 line presented no
significant increase, possibly due to a high amount of apoptotic
cells as shown below. The specificity of this effect could be
confirmed by the isogenic control line R495QfsX527c.1483insC.
Quantification of γH2A.X positive cells before and 24 h after
irradiation revealed that R495QfsX527c.1483insC (1.36 ± 0.08,
p ≤ 0.05) as well as R495QfsX527 (2.6 ± 0.11, p ≤ 0.05)
showed an increased number of γH2A.X+ cells 24 h after
DNA damage. This increase was much stronger in R495QfsX527
(p ≤ 0.001) expressing mFUS. Even without the induction
of DNA damage, an increased amount of γH2A.X positive
cells could be detectable for R495QfsX527 (1.65 ± 0.15,
p ≤ 0.01) compared to R495QfsX527c.1483insC (Supplementary
Figure S2F). Next, we classified the hiPSC colonies according to
morphological alterations after irradiation as being: (I) “healthy”
(oval nuclei, lying tightly next to each other), (II) apoptotic
colonies, (III) colonies with differentiated cells, and (IV) colonies
forming clumps due to poor adherence (Figure 2C). Twenty-
four hours after irradiation, all mFUS cell lines responded with
a significant increase in apoptotic colonies (Figure 2D). The
significant increase in the number of apoptotic colonies after
irradiation was 1.3 ± 0.2 fold (p ≤ 0.01) in the control cell
line and 1.0 ± 0.1 (p ≤ 0.01) and 2.0 ± 0.2 (p ≤ 0.01) fold
in R521C and R495QfsX527, respectively. A highly significant
increase (6.0± 0.3 fold, p≤ 0.001) of apoptotic colonies was seen
in the Asp502Thrfs∗27 line, in which most of the colonies were
apoptotic after irradiation (Figure 2D). Unpaired t-test was used
to compare non-irradiated versus irradiated cells within each
group (red asterisks) and a one way ANOVA with Bonferroni
post hoc test to compare the different groups. The number
of differentiated and clumping colonies after irradiation was
similar in the cell lines (data not shown). Finally, we evaluated
the amount of DNA breaks by the comet assay. To this end,
single cells of the colonies were γ-irradiated and the assay was
performed directly thereafter. The CNTL as well as the mFUS
cell line showed an increase in tail intensity after irradiation,
however, no significant differences were seen between these lines
(Figure 2E).
To confirm apoptosis induced by irradiation we also
immunostained for caspase-3 and found that caspase-3 positive
cells remained low in colonies from control cell line before
and after irradiation but increased substantially in cells derived
from the Asp502Thrfs∗27 cell line (Figure 3A). To quantify the
amount of caspase-3 activation, caspase-3 and the two cleaved
fragments (cl.casp-3 17 kDa and cl.casp-3 19 kDa) were analyzed
via western blot 1 and 24 h after irradiation. The amount of full-
length caspase-3 slightly decreased 1 and 24 h after irradiation
for CNTL (0.73 ± 0.01 fold after 1 h, 0.74 ± 0.07 fold after
24 h) and mFUS (0.86 ± 0.05 fold after 1 h, 0.82 ± 0.15
fold after 24 h). Unpaired t-test was performed to compare
untreated versus irradiated cells (red asterisks). Analysis of
cleaved caspase-3 revealed a significant increase in cl.casp-3
(17 kDa) and cl.casp-3 (19 kDa) 1 h after the induction of DNA
damage in mFUS Asp502ThrfS∗27 compared to the CNTL cell
line. This increase after 1 h was 7.5 ± 0.52 fold in the CNTL
cell line for cl.casp-3 (17 kDa) and 5.08 ± 0.3 fold for cl.casp-
3 (19 kDa). Cell line Asp502Thrfs∗27 showed a 4.2 ± 0.1 fold
increase in cl.casp-3 (17 kDa) and 6.59 ± 0.06 fold in cl.casp-3
(19 kDa) (Figure 3B).
In parallel, hiPSCs were also co-immunostained for FUS and
TIA1 before and 24 h after irradiation. In non-irradiated cells,
FUS was mainly distributed in the nuclei, however, the cell
line Asp502Thrfs∗27 presented a certain degree of cytoplasmic
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FIGURE 3 | Irradiation induces cytoplasmic FUS positive SGs and early apoptosis in mFUS-hiPSCs. (A) Undifferentiated control and mFUS-hiPSCs were
immunostained for caspase-3 (casp-3), after irradiation. In control and mFUS-hiPSCs caspase-3 positive cells were found within the hiPSC colonies. After irradiation
the number of caspase-3 positive cells within colonies was increased, especially in the mFUS line Asp502ThrfS∗27 cell line. (B) Western Blot analysis of control and
Asp502ThrfS∗27 hiPSCs 1 and 24 h after irradiation revealed a significant increase caspase-3 cleavage to cl.casp-3 (17 kDa) and cl.casp-3 (19 kDa) 1 h after the
induction of DNA damage in mFUS Asp502ThrfS∗27 compared to control. The amount of full-length caspase-3 decreased after irradiation for control and mFUS.
A significant reduction was seen in control 1 h after irradiation (casp-3 CNTL- vs. CNTL 1 h p ≤ 0.05). The amount of cleaved caspase-3 (17 kDa and 19 kDa)
increased 1 and 24 h after irradiation for control and mFUS (unpaired t-test to compare untreated versus irradiated cells was performed; indicated by red asterisks).
In comparison to control the values for the cleaved caspase 3 products were clearly enhanced in Asp502ThrfS∗27 cells. This effect was strongly significant after 1 h
of irradiation. (one way ANOVA with Bonferroni post hoc test). Values are shown relative to ß-actin. (C) HiPSCs were immunostained for FUS (in green) and the SGs
marker TIA1 (red) before and after irradiation. In control and mFUS-hiPSC lines FUS positive granules as well as TIA1 positive SGs were especially detected in the
mFUS Asp502ThrfS∗27 cell line. Arrowheads indicate areas of FUS+/TIA1+ SGs co-localization in the cytoplasm. (D) Quantification of these FUS aggregates after
irradiation shows a significant increase in all mFUS cells lines but not in CNTL. (unpaired t-test to compare non-irradiated versus irradiated cells from each cell line
was performed; indicated by red asterisks; groups were compared by one way ANOVA with Bonferroni post hoc test. ∗p ≤ 0.05, ∗∗p < 0.01, ∗∗∗p ≤ 0.001,
+ = irradiation (0.5 Gy), CNTL = control, mFUS = mutated FUS, SGs = stress granules. Scale bar: 10 µm.
FUS (Figure 3C, red arrowheads). TIA1 staining was also
mainly nuclear with some cytoplasmic staining (Figure 3C
insert, red arrowheads). After DNA damage we found a
significant increase in the number of cells that contained
cytoplasmic FUS forming aggregates that were positive for TIA1
(Figure 3C). In all mFUS cell lines, the number of cells with
FUS/TIA1 cytoplasmic inclusions was significantly increased
after irradiation. The most pronounced effect was seen in the
cell line with the Asp502Thrfs∗27 mutation with an significant
increase of 9.5 ± 0.1.4 fold (p ≤ 0.001) as opposed to increases
of 3.3 ± 1.3 (p ≤ 0.01) and 2.7 ± 0.5 (p ≤ 0.01) fold in R521C
and R495QfsX527, respectively and no significant increase in the
control cell line (0.7 ± 0.2 fold, p > 0.05) (Figure 3D). Unpaired
t-test was used to compare non-irradiated versus irradiated
cells within each group (red asterisk), one way ANOVA with
Bonferroni post hoc test to compare different lines).
Cytoplasmic FUS Mislocalization
Appears during Neuronal Aging and
Depends on the Severity of the FUS
Mutation in Spinal Motoneurons
Motoneurons differentiated from hiPSCs were tested for spinal
MN differentiation by immunostaining with antibodies directed
against TUJ1 (beta-III tubulin), NF-H, HB9, Islet-1 (ISL-
1), and ChAT (Supplementary Figure S3A). On day 21 of
motoneuron differentiation all cell lines developed a dense
neuronal network and expressed the early neuronal protein
marker beta-III tubulin (Supplementary Figure S3B). At this
stage, HB9 and Islet-1 (transcription factors specific for MNs)
as well as ChAT (characteristic for cholinergic MN) were also
detectable (Supplementary Figure S3A). At day 42, the neuronal
network had matured in all cell lines and contained dense NF-H
positive filaments (Supplementary Figure S3C).
Within developing and mature MN, FUS was predominantly
localized in the nucleus of all 21-day-old MNs (Figure 4).
Similar to controls, neurons carrying the benign missense
mutation R521C exhibited an exclusive nuclear localization of
the FUS protein. However, cytoplasmic FUS was detectable in
some MNs expressing mFUS with the frame shift mutation
R495QfsX527. In contrast, almost every cell harboring the
most severe mutation Asp502Thrfs∗27 contained cytoplasmic
FUS (Figure 4A). To visualize motoneuronal cell bodies as
well as dendrites, differentiated cells were stained for MAP-2
(Figure 4B).
FUS Granules Are Regularly Found in
Neurites of iPSC Derived MN
At day 42 of neuronal differentiation, FUS was localized to the
nucleus of control cells (Figure 4B), in patient-derived cells, the
protein was in addition detectable in the cytoplasm of almost
every neuronal cell carrying mFUS R521C, R495QfsX527 and
Asp502Thrfs∗27. In particular, MNs with the mFUS R521C
displayed some FUS protein in the cytoplasm as well as along
dendrites (Figures 4B and 5). MNs carrying the malignant FUS
mutations R495QfsX527 or Asp502Thrfs∗27 showed a signal for
FUS in cytoplasm and FUS inclusions within the cytoplasm and
along the MAP-2 or NF-H positive neurites (Figure 4B, red
arrowheads and Figure 5). FUS+ punctae were especially seen
in neurites of patient-derived MN, especially Asp502Thrfs∗27
derived MNs had an aberrant and an increased amount of
large FUS+ punctae (Figure 5, red arrowheads). In contrast to
MNs expressing the mFUS variant R495QfsX527 the CRISPR
corrected cell line R495QfsX527c.1483insC showed only nuclear
FUS in differentiated MN (Supplementary Figure S2E, red arrow
heads).
Interestingly, several mature 42-day-old MN derived from
cell line Asp502Thrfs∗27 showed FUS immunoreactivity that
was almost excluded from the nucleus and shifted completely
to the cytoplasm (Figure 6A). To quantify the amount of
cytoplasmic and nuclear FUS, we measured the intensity (mean
gray value) of FUS in the cytoplasm and/or in the nuclei of
NF-H positive MN (Figures 6B,C). In controls the homogenous
cell population showed low values for the cytoplasm and high
intensities for the nuclei. In MN carrying the Asp502ThrfS∗27
mutation two separated MN populations could be identified
according to their nuclear staining. They either had a very
reduced nuclear FUS value (mean gray value of 452.1 ± 51.23,
p ≤ 0.001) or a significantly higher intensity (mean gray
value of 3759 ± 46.78, p ≤ 0.001) (Figure 6B, highlighted by
arrow heads). In the cytoplasm, there was a significant higher
amount of cytoplasmic FUS in Asp502ThrfS∗27 (mean gray
value of 6393 ± 23.26) compared to CNTL (mean gray value of
263.3± 12.73, p ≤ 0.001).
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FIGURE 4 | Cytoplasmic FUS mislocalization depends on motoneuron aging and FUS mutation type. (A,B) Immunostaining of FUS (green) in spinal
motoneurons at different stages of motoneuronal development. (A) In TUJ1 positive (red) 21 days old motoneurons FUS is predominantly found in the nuclei. Little
spots of cytoplasmic FUS was detectable only in cells expressing Asp502ThrfS∗27 and R495QfsX527 FUS. (B) In MAP2 positive (red) 42 days old control
motoneurons FUS is still confined to the nuclei. Cytoplasmic FUS and FUS positive granules along neurites were detected in R521C, R495QfsX527 and
Asp502ThrfS∗27 derived motoneurons. Motoneurons with the malign R495QfsX527 and severe Asp502Thrfs∗27 FUS mutation presented larger FUS deposits
within the cytoplasm compared to the R521C cell line. Scale bars: 10 µm.
The two populations of Asp502ThrfS∗27 MN were further
characterized by a correlation analysis taking cytoplasmic and
nuclear intensity of each single cell into account. In contrast
to CNTL the mFUS cells were splitted into two populations
with high cytoplasmic intensity and either low nuclear intensity
(Figure 6C, arrow ∗1) or high nuclear intensity (Figure 6C,
arrow ∗2). The thorough analysis of the first subgroup (∗1)
displaying a high degree of cytoplasmic FUS were found to be
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FIGURE 5 | mFUS-hiPSCs derived motoneurons are characterized by an increased number of large FUS+ granules along neurites. Immunostaining of
FUS (green) in mature 42-day-old motoneurons showed FUS positive granules along NF-H+ (magenta) neurites in control and mFUS-hiPSCs derived cells. FUS
positive granules or small punctae were observed regularly in control cells; in mFUS motoneurons several, larger FUS positive granules were detected along the
neurites. mFUS = mutated FUS, scale bars: 10 µm.
also displacing large FUS+ granules along the neurites. Neurites
derived from healthy CNTL showed 5.5 ± 0.8 FUS+ granules
per 10 µm whereas Asp502Thrfs∗27 presented significantly more
FUS+ granules (13.9 ± 1.7, p ≤ 0.001) (Figures 6D,E). In
addition, in CNTLs the average size of the FUS+ granules was
0.17 ± 0.004 µm2, whereas the granules found in the mFUS
Asp502Thrfs∗27 line where significantly larger (0.4± 0.013 µm2)
(p ≤ 0.001) (Figure 6E, dot blot). Unpaired t-test was used to
compare CNTL versus mFUS cells.
mFUS Motoneurons Show an Increased
Number of SGs along Neurites
In order to further characterize these FUS+ granules along
mature neurites, the intracellular distribution of TIA1 positive
SGs in 42 days old MN was investigated. Similar to cells
expressing WT FUS, MNs carrying FUS mutations exhibited a
predominantly nuclear expression of TIA1. In addition, TIA1+
inclusions were found along the neurites and partially co-
localizing with FUS in control cell lines as well as in mFUS
MN (indicated by yellow arrowheads in Figure 6D). In cells
expressing mFUS, however, there were notably more and larger
TIA1/FUS positive granules than in control MNs. Neurites
derived from CNTL cell lines showed an average of 9.0 ± 0.8
TIA1+ SGs per 10 µm length whereas Asp502Thrfs∗27 presented
a significant increase by having an average of 16.3 ± 1.05
TIA1 granules per 10 µm (p ≤ 0.001) (Figure 6F). The ratio
of co-localization between FUS and TIA1 granules showed
no differences (p > 0.05) between CNTL (46.6 ± 3.2%) and
mFUS Asp502ThrfS∗27 (42.1 ± 4.2%) (Figure 6G), but in line
with the elevated number of FUS+ granules per se there is a
significant increase of FUS positive TIA1 foci in cells expressing
Asp502ThrfS∗27 (5.9 ± 1.0) compared to CNTL (3.1 ± 0.6,
p ≤ 0.05, unpaired t-test to compare CNTL versus mFUS)
(Figure 6G).
Motoneurons Expressing mFUS Are
Characterized by Increased DNA
Damage Foci
As already performed for iPS cells, we next analyzed the amount
of DNA-damage in young (21 days old) and mature (42 days
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FIGURE 6 | Characterization of FUS expression and localization in mFUS motoneurons. (A) Mature, 42-day-old motoneurons derived from mFUS
Asp502ThrfS∗27 were immunostained for FUS (green) and NF-H (magenta) to identify FUS alterations associated with the severity of the FUS mutation. In some cells
a drastic mislocalization could be identified (as indicated by red arrowheads). In those motoneurons, a large number of FUS+ granules along the neurites were
detectable and FUS was almost completely absent from the nuclei (blue circle) and found strongly positive in the cytoplasm (green circle). (B) Quantification of this
observation by intensity measurements (mean gray value) revealed significant values for cytoplasmic FUS in Asp502ThrfS∗27 motoneurons compared to control
(unpaired t-test). In control, the measurements of nuclear areas resulted in one homogenous cell population; in Asp502ThrfS∗27 motoneurons two separated cell
populations were identified (red arrows). (C) These two cell populations are further characterized in a diagram, showing individual values for cytoplasmic (y-axis) and
nuclear (x-axis) intensity measurements of the analyzed motoneurons. The two Asp502ThrfS∗27 cell populations, which clearly differ in the nuclear amount of FUS,
are highlighted by ∗1 and ∗2. (D) Mature spinal motoneurons were stained for FUS (green) and TIA1 (red). FUS was detectable in the nuclear compartment in control
cells, cytoplasmic FUS was detectable only in motoneurons expressing mFUS. In control and mFUS motoneurons, TIA1 was seen in the nucleus but also in
cytoplasm. Neurites from 42 days old spinal motoneurons showed FUS+ granules in control and in mFUS cells. The number of those granules were largely
increased in motoneurons expressing mFUS. Moreover, TIA1+ SGs were detectable in control but to a higher degree and increased size in mFUS-hiPSCs derived
neurites. FUS+ and TIA1+ foci are shown per 10 µm neurite length (E) Quantification of FUS+ foci showed a significant increase in the number of foci in mFUS cells.
The size of the FUS+ foci was also increased in Asp502ThrfS∗27, as highlighted by the green insert. (F) Quantification of TIA+ SGs revealed an increase in the
granules number along the neurites in mFUS, that were also larger compared to control as highlighted by the red insert. (G) Co-localization analysis showed that
there is an increased degree of FUS+ TIA1 foci per 10 µm in Asp502ThrfS∗27. The overall percentage of co-localized FUS and TIA1, however, is similar in control
and mFUS. ∗p ≤ 0.05 and ∗∗∗p ≤ 0.001; SGs = stress granules; CNTL = control; and mFUS = mutated FUS. Scale bars: 10 µm.
old) MNs 24 h after γ-irradiation. MNs were classified either
negative (I) or positive (II) for DNA damage foci as indicated
by γH2A.X+ labeling (Figure 7A, red arrowheads). Interestingly,
we found that even in non-stressed 21 days old MNs the number
of cells containing γH2A.X+ foci was significantly higher in the
mFUS Asp502Thrfs∗27 line (5.0 ± 0.6 fold) compared to control
(1.0± 0.2, p≤ 0.01). Both neuronal lines responded to irradiation
by showing a significant increase in cells containing positive
γH2A.X foci in the nuclei (8.9 ± 2.0 fold in CNTL and 9.9 ± 2.0
fold in Asp502Thrfs∗27, p ≤ 0.001; Figure 7B). This increase of
γH2A.X positive neurons after irradiation was not significantly
different between the two cell lines. Similar to young cells,
the non-stressed 42 days old MNs expressing Asp502Thrfs∗27
exhibited a significant increased number of γH2A.X+ cells
(1.9 ± 0.1 fold) compared to control (1.0 ± 0.09, p ≤ 0.05).
After irradiation, all lines responded with an increase of γH2A.X
positive neurons (2.9 ± 0.2 fold in CNTL and 4.0 ± 0.2 fold in
Asp502Thrfs∗27, p≤ 0.001). Unpaired t-test was used to compare
non-irradiated versus irradiated within each cell line. However,
different from the iPSCs (Asp502Thrfs∗27), the increase of
DNA damage positive cells after irradiation was significantly
increased for stressed mFUS compared to stressed CNTL
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FIGURE 7 | mFUS motoneurons show signs of increased DNA damage which are potentiated after irradiation. (A) 21 days old motoneurons before and
24 h after irradiation were immunostained by γH2A.X (green) and categorized either negative (I) or positive (II) for DNA damage. (B) Even before γ-irradiation the
amount of DNA damage was significantly increased in 21 and 42 days old motoneurons expressing Asp502ThrfS∗27. After irradiation the control as well as the
Asp502ThrfS∗27 cell line showed an increased number of γH2A.X+ cells compared to non-irradiated; 42 days old motoneurons expressing mFUS show more DNA
damage compared to control. Results are displayed relative to the non-irradiated control line (unpaired t-test; comparison of cell lines was performed by one way
ANOVA with Bonferroni post hoc test). (C) The effect of maturation (21 vs. 42 days old motoneurons) on γH2A.X+ cells revealed significant results for control as well
as for Asp502ThrfS∗27 (unpaired t-test). (D) 21 days old cells before and 24 h after irradiation were stained for FUS. Without irradiation FUS is predominantly present
in the nucleus in control and Asp502ThrfS∗27 cells. Some cytoplasmic FUS staining is seen in young mFUS cells. After irradiation, in control as well as
Asp502ThrfS∗27 FUS is mislocalized to the cytoplasm (insert II, red arrowheads) in some motoneurons. In addition to this Asp502ThrfS∗27 motoneurons show large
positive FUS inclusions (insert II, red arrowheads). ∗p ≤ 0.05, ∗∗p ≤ 0.01, and ∗∗∗p ≤ 0.001; CNTL, control and mFUS, mutated FUS. Scale bars: 10 µm.
(p ≤ 0.01, one way ANOVA with Bonferroni post hoc test to
compare different lines before and after irradiation) (Figure 7B).
A comparable result was seen using the isogenic control line
R495QfsX527c.1483insC underlining the assumption that mFUS
is most likely responsible for the observed phenotype. Here,
an effect of irradiation was only seen for R495QfsX527c.1483insC
showing an increase of 1.8 ± 0.12 (p ≤ 0.001, unpaired t-test)
24 h after irradiation. Again, differences between the mutated
and rescued cell line was detectable even before and after
irradiation of mature motoneurons. Compared to non-irradiated
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R495QfsX527c.1483insC, non-irradiated R495QfsX527 showed
higher numbers of γH2A.X+ cells (2.8 ± 0.19, p ≤ 0.001).
Although irradiation had no obvious effect on R495QfsX527
(2.7 ± 0.2), significantly more γH2A.X+ cells were detectable
compared to irradiated R495QfsX527c.1483insC (1.8 ± 0.12,
p ≤ 0.001) (Supplementary Figure S2F).
Finally, we analyzed the number of DNA damage foci
during motoneuronal maturation. Young 21 days old CNTL-
MN showed only a 2.0 ± 0.6% of γH2A.X positive cells whereas
11.6± 1.0% γH2A.X positive cells were present in mature 42 days
old cultures (p ≤ 0.001). DNA damage levels were generally
increased in mFUS cells. Twenty-one days old Asp502Thrfs∗27-
MN exhibited 10.4 ± 1.4% γH2A.X positive cells; whereas in
42 days old MN 22.9 ± 1.835% of the cells were positive for
foci of DNA damage (p ≤ 0.001, unpaired t-test to compare
21 days versus 42 days) (Figure 7C). To study the effect of
DNA-damage on FUS localization in young MN, we also stained
for FUS. In young CNTRL-MN, FUS is localized in the nuclei,
after irradiation FUS could partially be seen in the cytoplasm
(Figure 7D). After irradiation of young mFUS-MN cultures large
FUS clusters were detected in the cytoplasm in nearly all neurons
compared non-stressed cells (Figure 7D, arrowheads).
DISCUSSION
Since the discovery of specific gene mutations leading to
ALS, several model systems have been established to analyze
pathomechanisms leading to a selective degeneration of MNs.
With respect to FUS, there have been publications on different
murine models with inconsistent pathologies. For example,
transgenic mice overexpressing human WT FUS exhibited MN
degeneration, an ALS hallmark, indicating a toxic effect of
elevated FUS levels (Huang et al., 2011). However, in rats it
was only the overexpression of mFUS and not WT FUS that
induced motor deficits (Mitchell et al., 2013). Moreover, FUS
inclusions, which are detectable in brains and spinal cords of
ALS patients (Vance et al., 2009; Dormann et al., 2010) could
be induced in rodents by overexpressing WT as well as mFUS
(Huang et al., 2011). However, the phenotype was more severe
and the inclusions more frequent in cells expressing mFUS,
indicating that mFUS is more toxic to neurons. Therefore, it
is tempting to speculate that mutations disrupting the protein
structure may not only be completely responsible for the disease
but also changes in FUS protein levels. In fact, mutations in
the 3′-UTR of the FUS gene that lead to increased FUS levels
through an altered feed-forward regulatory loop, are associated
with ALS (Dini Modigliani et al., 2014), suggesting that FUS has
to be properly regulated to avoid pathology. Non-neuronal cells,
which do not recapitulate the complexity of neurons, as well as
neurons have also been extensively used in vitro as valuable tools
to analyze cell specific responses but only by overexpressing WT
or mFUS (Dormann et al., 2010; Bentmann et al., 2012; Jäckel
et al., 2014).
In our study, we took advantage of the hiPSC technology to
generate patient specific cell lines, avoiding the overexpression of
the protein, and test whether these cells were able to recapitulate
ALS pathology in undifferentiated hiPSC and in selectively
differentiated spinal MNs. We generated a novel iPS cell line
from a juvenile ALS patient presenting with a frame shift FUS
mutation in the RGG-rich region Asp502Thrfs∗27 (Hübers et al.,
2015) and compared it with our previously described cell lines
R521C and R495QfsX527 (Japtok et al., 2015). In iPS cells under
physiological in vitro conditions FUS was only mislocalized in the
cell line Asp502Thrfs∗27 but not in the other cell lines in which
mFUS remained mainly nuclear.
The induction of hyperosmolar stress by sorbitol treatment,
however, led to FUS+ granules seen in the cytoplasm co-
localizing with the SGs marker and mRNA binding protein TIA1.
The number cells containing cytoplasmic FUS+ granules after
sorbitol treatment was significantly higher in cells expressing
mFUS compared to controls. This increase was nearly identical
in all mFUS cell lines, indicating that this phenotype was not
associated with the severity of the underlying FUS mutation as it
was shown for oxidative stress before (Lenzi et al., 2015). These
observations recapitulate published data on the recruitment of
FUS and mFUS into SGs as described in hiPSC and differentiated
MN (Lenzi et al., 2015) and reviewed by (Sama et al., 2014a).
This result might suggest a physiological or protective role of
WT FUS within the stress response (Sama et al., 2014b), whereas
mFUS+ SGs are more pathogenic. Since it is known that osmotic
stress enhanced the degeneration of motoneurons in a C. elegans
model of ALS (Therrien et al., 2013) this kind of stress condition
may also contribute to ALS pathology by a transformation of
reversible FUS positive SGs into pathological inclusions.
Fused in sarcoma has also been shown to be involved in
DNA damage and DNA repair by interacting directly with
HDAC1. As shown by Wang et al. in HEK cells, FUS is recruited
to DNA repair sites allowing proper DDR signaling (Wang
et al., 2013). Interestingly, these authors showed that impaired
efficiencies in DNA repair might also be depending upon the
site of mutation. In this study, we have tested the degree of
DNA damage and repair in two types of human cells: (I) In
hiPSC, which divide rapidly and show high levels of DNA repair
and (II) in MN, which are postmitotic, slower DNA repairing
cells. Interestingly, we found opposing results for these two cell
types. In iPSCs, the degree of DNA damage was very low and
no differences were found between control and mFUS cell lines.
After the induction of double strand breaks by irradiation, DNA
damage was increased but no differences between WT and mFUS
were encountered as assessed by the comet assay directly after
irradiation. However, differences between WT and mFUS cell
lines are detectable at the morphological level when cells were
left to repair for 24 h. The number of colonies who underwent
apoptosis after irradiation was significantly higher in mFUS cells
indicating that cells expressing WT FUS restore their DNA more
efficiently compared to cells expressing a mFUS variant. This
aspect could be substantiated by the analysis of active caspase-
3 as an apoptotic marker protein. In the mutant R495QfsX527
we also detected an increase in the amount of cells containing
DNA damage foci after 24 h of irradiation, indicating that this
FUS mutation seems to cause an inefficient DNA repair. Reduced
differences were seen for the mild mutation, demonstrating that
this mutation may have a weaker effect (Wang et al., 2013). For
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FIGURE 8 | Extra-nuclear FUS-localization depends on neuronal aging and severity of the mutation. (A) Diagram showing how mFUS and neuronal aging
influence the degree of DNA damage in differentiated motoneurons. There is an increase in DNA damage during aging in healthy control and mFUS cells. However, in
young and mature motoneurons the accumulation of DNA damage is higher compared to control in each case. (B) Diagram showing how neuronal aging and the
severity of mutation influence FUS localization in hiPSCs-derived motoneurons and thereby contribute to the formation of pathological FUS+ inclusions. Motoneurons
derived from neuronal healthy volunteers expressing wildtype FUS present a predominantly nuclear FUS localization during early and later neuronal development.
Furthermore, mature motoneurons show FUS along neurites within defined punctae. In motoneurons derived from ALS-FUS patients expressing mFUS the protein is
also localized mainly nuclear during early neuronal development. In cells expressing mFUS with a severe mutation, cytoplasmic mislocalization starts earlier and is
already detectable in 21 days old motoneurons. In mature mFUS cells (42 days), two separated cell populations, which differ in the nuclear amount of FUS are
present, one with a higher amount of FUS and another one with FUS almost completed shifted to the cytoplasm. CNTL, control and mFUS, mutated FUS.
the most aggressive mutation, the percentage of cells containing
DNA damage foci was unchanged, but most likely because cells
were already apoptotic and the DNA damage in apoptotic cells
could not be assessed.
When we induced double strand breaks in spinal MN
derived from FUS patients and healthy controls we tested the
hypothesis that the induction of DNA damage could be a
putative second hit leading to MN degeneration (Madabhushi
et al., 2014). Interestingly, compared to iPSCs, which showed
no differences in DNA damage in non-irradiated conditions,
21 days old MN expressing mFUS Asp502Thrfs∗27 exhibited a
significantly increased number of DNA damage foci, suggesting
the accumulation of DNA damage as an early event that might
indeed induce disease pathology, furthermore, an accumulation
of DNA damage foci was associated with aging of the MN
(as represented in Figure 8A). Different studies have already
shown the association of FUS function in DNA repair and
genome instability. KO FUS mice die at birth and show genomic
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instability (Hicks et al., 2000) and fibroblasts derived from
these mice are very sensitive to radiation (Hicks et al., 2000;
Kuroda et al., 2000). FUS also induced the annealing of DNA-
loops by homologous recombination, a crucial step in DNA
repair (Naro et al., 2015). Similar, to what we detected in our
mFUS derived MN, an accumulation of DNA damage was also
seen in post mortem cortex sections of fALS patients harboring
FUS mutations (Wang et al., 2013) and the spinal cord of
mice expressing a FUS mutation (Qiu et al., 2014). Recently,
it has also been shown that WT FUS is affected after DNA
damage by being phosphorylated at the N terminus and being
translocated into the cytoplasm (Deng et al., 2014). In our study,
the irradiation of young MN from a control subject resulted
in FUS protein translocated into the cytoplasm and therefore,
mimicking pathological changes that occur in FTD-FUS and
ALS-FUS. In mFUS-MN, irradiation induced an even more
extreme phenotype by forming large FUS positive cytoplasmic
inclusions. Altogether, the data suggest that the accumulation of
DNA damage in mFUS may be an early, crucial event that triggers
the pathological changes detected in neurodegeneration of MN in
ALS related diseases (Madabhushi et al., 2014).
Finally, FUS is known to transport RNA from the nucleus
to the cytoplasm being associated with several motor proteins
(Kanai et al., 2004; Yoshimura et al., 2006; Takarada et al.,
2009). In neurons, FUS is found at synaptic sites indicating
that it might be important for local translation of transported
mRNA (Fujii and Takumi, 2005; Fujii et al., 2005; Yasuda
et al., 2013; Sephton et al., 2014) and involved in synaptic
plasticity (Fujii et al., 2005; Aoki et al., 2012; Schoen et al.,
2016). Therefore, we investigated the localization of FUS in
control and patient-derived MNs and analyzed a FUS associated
pathology in axons and/or dendrites. We have previously shown
that iPSC-derived MNs express a wide set of synaptic markers
after 42 days in culture and establish mature synaptic contacts
with the ability to generate action potentials (Stockmann et al.,
2013). In young, 21 days differentiated MNs, FUS was mainly
localized in nuclei, except for the most aggressive mutation
in which FUS was already translocated into the cytoplasm. In
mature 42 days differentiated MN from control cell lines, FUS
was not only localized in the nuclei (Japtok et al., 2015; Lenzi
et al., 2015; Liu et al., 2015) but was also detectable as small
punctae along the neurites. This observation was very similar to
the FUS localization along neurites and within the presynaptic
compartment in hippocampal neurons (Schoen et al., 2016).
In 42 days old MN from cell lines harboring mFUS, the protein
was mainly seen in the nuclei but also distributed within the
cell body at different degrees. This degree of mislocalization
was directly associated with the clinical onset of the disease.
The milder mutation R521C, with a late onset, presented only
some FUS mislocalization, while the amount of cytoplasmic FUS
distribution was higher in the other two most severe mutations.
In these cases, small FUS+ inclusions were also detected within
the cytoplasm (Figure 8B). In addition, in the cell line harboring
the most severe mutation, with an early juvenile onset, we could
identify two subgroups of MN with high amounts of cytoplasmic
FUS and either low or high nuclear FUS levels. In these MN the
degree of punctuated FUS along the neurites was much stronger
and abundant compared to controls. Furthermore, some of these
large FUS punctae co-localized with SG marker, which were also
present along the neurites. This indicates, that in mFUS, FUS is
spontaneously aberrantly distributed along the axons, as opposed
to iPSCs, in which as stressor was needed to see changes in FUS
mislocalization and SG formation (Lenzi et al., 2015; Ichiyanagi
et al., 2016). It is quite conceivable that these mFUS clusters
affect local mRNA translation at the synapse and contribute to
the synaptic loss in ALS related neurodegenerative disease.
In summary, we have been able to reproduce in human
iPSC derived MN some crucial pathological hallmarks seen in
ALS such as (I) the cytoplasmic FUS mislocalization, (II) the
formation of FUS+ inclusions (Japtok et al., 2015; Lenzi et al.,
2015; Ichiyanagi et al., 2016) as well as (III) an increased DNA
damage in MN (Wang et al., 2013; Qiu et al., 2014). Moreover,
FUS was seen to build up large clusters in neurites, especially in
mFUS cell lines carrying aggressive mutations. Undifferentiated
hiPSCs were less sensitive to mFUS and did not show an obvious
cellular phenotype. This could, however, be induced by specific
stressors, and mFUS cell lines were more vulnerable to DNA
damage.
On the basis of a two hit hypothesis, we conclude that the first
hit is the modification of the FUS gene leading to a cytoplasmic
mislocalization of mFUS in MN depending upon the severity
of the mutation that correlates with the onset of the disease
(early onset, higher degree of FUS mislocalization). The second
hit is an external factor such as DNA damage or stress. In
young control cells, FUS was mislocalized only after the induction
of DNA damage, in mFUS large FUS positive inclusions were
seen. A strong FUS mislocalization was also detectable in older
mFUS MNs. We hypothesize that this is due to neuronal
maturation/aging and a later event during ALS pathology. In
hiPSC derived MNs only a few larger FUS+ inclusions were
detected giving rise to the supposition that possibly a third hit
is needed to increase the size and toxicity of FUS inclusions that
finally induce neuronal degeneration.
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FIGURE S1 | Pluripotency characteristics of the newly generated FUS3
line Asp502ThrfS∗27. (A–D) The newly generated iPSC cell line Asp502ThrfS∗27
was tested for specific markers to ensure pluripotency. (A) The hiPS cell line
expressed the nuclear factors (all green) octamer- binding transcription factor 4
(OCT4), sex determining region Y-box 2 (SOX2) and nanog homeobox (NANOG)
and the characteristic surface markers (all red) stage-specific embryonic antigen 4
(SSEA-4), tumor-related antigen (TRA) 1-60 and TRA1-81. (B) Undifferentiated
iPSCs showed high endogenous mRNA levels for OCT4, SOX2, and NANOG,
whereas KLF4 levels are low compared to keratinocytes. Expression levels are
shown relative to the housekeeping gene HMBS. (C) The iPSC colonies were able
to differentiate into all three germ layers. Immunostainings showed cells positive
for ectodermal (tubulin-β-II), mesodermal (actinin) and endodermal (AFP) protein
markers. Scale bars: 50 µm. (D) Cell line Asp502ThrfS∗27 represented a normal
male karyotype (46, XY) after the reprogramming process. (E) The localization of
FUS in all control (CNTL1-3) and ALS-FUS patient-derived hiPSCs lines (R521C,
R495QfsX527, Asp502ThrfS∗27) was predominantly limited to the nucleus. In
some cells, low amounts of cytoplasmic FUS could be observed. hiPSC line
FUS3, expressing mFUS Asp502ThrfS∗27, displayed higher amounts of
cytoplasmic FUS compared to the other cell lines. Scale bars: 10 µm.
FIGURE S2 | The isogenic control R495QfsX527c.1483insC line shows no
cytoplasmic FUS mislocalization. (A) Illustration, showing the DNA and amino
acid (AA) sequence of the patient cell line R495QfsX527and the corrected cell line
R495QfsX527c.1483insC, in which a C-nucleotide at position 1483 of exon 14 was
inserted via CRISPR technology. The novel 1 bp deletion c.1483delC (highlighted
in red) leads to a frameshift (gray arrow) and the translation of new AAs before the
STOP codon at AA-position 540. (B) Alignment of the sequencing results of
genomic CNTL and R495QfsX527c.1483insC revealed no further alteration within
the fragment besides the C-insertion (shown in red) and the two PAM sequences
(both green). (C) The “rescued” cell line R495QfsX527c.1483insC was tested for
specific pluripotency markers. The hiPS cell line expressed the nuclear factors (all
green) SOX2, OCT4 and NANOG and the characteristic surface markers (all red)
SSEA-4, TRA1-60 and TRA1-81. R495QfsX527c.1483insC showed high
endogenous mRNA levels for SOX2, OCT4 and NANOG, whereas KLF4 levels
were low. Expression levels are shown relative to the housekeeping gene HMBS.
(D) The localization of FUS in R495QfsX527 expressing mFUS and
R495QfsX527c.1483insCexpressing the corrected protein was predominantly limited
to the nucleus in hiPS cells. In both cell lines, low amounts of cytoplasmic FUS
could be observed in only some cells. (E) In contrast to motoneurons expressing
R495QfsX527,in which cytoplasmic FUS and FUS+ granules along the neurites
were detected, the corrected version R495QfsX527c.1483insCshowed
predominantly nuclear FUS with only small amount of cytoplasmic FUS. (F)
Quantification of γH2A.X+ cells before and 24 h after irradiation in hiPSCs and
mature motoneurons. Results are displayed relative to untreated repaired control
line. After irradiation, the R495QfsX527 as well as R495QfsX527c.1483insC cell line
showed an increased number of γH2A.X+ cells compared to non-irradiated and
even differences amongst cell lines were detectable before and after irradiation in
hiPS cells (unpaired t-test, comparison of cell lines was performed by one way
ANOVA with Bonferroni post hoc test) ∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001 All
scale bars: 10 µm.
FIGURE S3 | hiPSC-derived motoneurons express specific motoneuronal
markers and develop a dense neuronal network. (A) Twenty-one days old
motoneurons were immunostained for motoneuronal markers HB9, Islet-1 (ISL-1)
and choline acetyltransferase (ChAT) (all in green) to demonstrate motoneuron
differentiation. At this stage, differentiated hiPSCs expressed the subtype specific
markers HB9 and ISL-1, transcription factors, localized in the nucleus of the cells.
Additionally, motoneurons were positive for ChAT. (B,C) Developing motoneurons
were tested for the neuronal marker Tubulin beta-III (TUJ1) (blue) and the axonal
marker neurofilament heavy chain (NF-H) (magenta). On day 21 of motoneuronal
differentiation all control and mFUS-derived cell lines developed a dense neuronal
network, positive for the early motoneuronal marker TUJ1 (B). From day 42
onwards the neuronal network becomes more complex and cells expressed the
subtype specific axonal marker NF-H (C). Scale bars:10 µm.
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